Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deficient butyrate metabolism in the intestinal microbiome is a potential risk factor for recurrent kidney stone disease

28 Feb 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gut microbiota and health
Share to Kidney Stones and Urolithiasis Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38413462
DOI: 10.1007/s00240-024-01534-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deficient butyrate metabolism in the intestinal microbiome is a potential risk factor for recurrent kidney stone diseasePMID 38413462Read ↗

Butyrate producing microbiota are reduced in chronic kidney diseasesSemantic proximity Read ↗

The interplay between gut microbiota, short-chain fatty acids, and implications for host health and diseaseSemantic proximity Read ↗

Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formersSemantic proximity Read ↗

The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and interventionSemantic proximity Read ↗

Gut microbial-derived short chain fatty acids enhance kidney proximal tubule cell secretory functionSemantic proximity Read ↗

Metabolic interplay of SCFA’s in the gut and oral microbiome: a link to health and diseaseSemantic proximity Read ↗

Microbiome in Chronic Kidney Disease (CKD): An Omics PerspectiveSemantic proximity Read ↗

Gut microbiome and kidney stone disease: not just an Oxalobacter storySemantic proximity Read ↗

Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary CholangitisSemantic proximity Read ↗

Defining Dysbiosis for a Cluster of Chronic DiseasesSemantic proximity Read ↗

Chronic kidney disease and the gut microbiomeSemantic proximity Read ↗

Role of the Gut Microbiome in Uremia: A Potential Therapeutic TargetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.